BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25537191)

  • 1. TG-interacting factor mediates arsenic-induced malignant transformation of keratinocytes via c-Src/EGFR/AKT/FOXO3A and redox signalings.
    Liu ZM; Tseng HY; Yeh BW; Wu WJ; Huang HS
    Arch Toxicol; 2015 Dec; 89(12):2229-41. PubMed ID: 25537191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TG-interacting factor transcriptionally induced by AKT/FOXO3A is a negative regulator that antagonizes arsenic trioxide-induced cancer cell apoptosis.
    Liu ZM; Tseng HY; Cheng YL; Yeh BW; Wu WJ; Huang HS
    Toxicol Appl Pharmacol; 2015 May; 285(1):41-50. PubMed ID: 25791921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells.
    Liu ZM; Tseng JT; Hong DY; Huang HS
    Biochem J; 2011 Sep; 438(2):349-58. PubMed ID: 21649584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NADPH oxidase-produced superoxide mediates EGFR transactivation by c-Src in arsenic trioxide-stimulated human keratinocytes.
    Tseng HY; Liu ZM; Huang HS
    Arch Toxicol; 2012 Jun; 86(6):935-45. PubMed ID: 22532027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor β-interacting factor-induced malignant progression of hepatocellular carcinoma cells depends on superoxide production from Nox4.
    Liu ZM; Tseng HY; Tsai HW; Su FC; Huang HS
    Free Radic Biol Med; 2015 Jul; 84():54-64. PubMed ID: 25841779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TG-interacting factor-induced superoxide production from NADPH oxidase contributes to the migration/invasion of urothelial carcinoma.
    Huang HS; Liu ZM; Chen PC; Tseng HY; Yeh BW
    Free Radic Biol Med; 2012 Aug; 53(4):769-78. PubMed ID: 22728270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant overexpression of FOXM1 transcription factor plays a critical role in lung carcinogenesis induced by low doses of arsenic.
    Liu Y; Hock JM; Van Beneden RJ; Li X
    Mol Carcinog; 2014 May; 53(5):380-91. PubMed ID: 23255470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barium promotes anchorage-independent growth and invasion of human HaCaT keratinocytes via activation of c-SRC kinase.
    Thang ND; Yajima I; Kumasaka MY; Ohnuma S; Yanagishita T; Hayashi R; Shekhar HU; Watanabe D; Kato M
    PLoS One; 2011; 6(10):e25636. PubMed ID: 22022425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular determinants of Akt-induced keratinocyte transformation.
    Segrelles C; Moral M; Lara MF; Ruiz S; Santos M; Leis H; García-Escudero R; Martínez-Cruz AB; Martínez-Palacio J; Hernández P; Ballestín C; Paramio JM
    Oncogene; 2006 Feb; 25(8):1174-85. PubMed ID: 16247457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Akt activation is responsible for enhanced migratory and invasive behavior of arsenic-transformed human bronchial epithelial cells.
    Wang Z; Yang J; Fisher T; Xiao H; Jiang Y; Yang C
    Environ Health Perspect; 2012 Jan; 120(1):92-7. PubMed ID: 21954225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PI-3K/Akt pathway-dependent cyclin D1 expression is responsible for arsenite-induced human keratinocyte transformation.
    Ouyang W; Luo W; Zhang D; Jian J; Ma Q; Li J; Shi X; Chen J; Gao J; Huang C
    Environ Health Perspect; 2008 Jan; 116(1):1-6. PubMed ID: 18197291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced carcinogenicity by coexposure to arsenic and iron and a novel remediation system for the elements in well drinking water.
    Kumasaka MY; Yamanoshita O; Shimizu S; Ohnuma S; Furuta A; Yajima I; Nizam S; Khalequzzaman M; Shekhar HU; Nakajima T; Kato M
    Arch Toxicol; 2013 Mar; 87(3):439-47. PubMed ID: 23100159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PI-3K/Akt signal pathway plays a crucial role in arsenite-induced cell proliferation of human keratinocytes through induction of cyclin D1.
    Ouyang W; Li J; Zhang D; Jiang BH; Huang DC
    J Cell Biochem; 2007 Jul; 101(4):969-78. PubMed ID: 17370311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different pathways are involved in arsenic-trioxide-induced cell proliferation and growth inhibition in human keratinocytes.
    Bi X; Gu J; Guo Z; Tao S; Wang Y; Tang L; Wu J; Mi Q
    Skin Pharmacol Physiol; 2010; 23(2):68-78. PubMed ID: 20016248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of TG-interacting factor is associated with worse prognosis in upper urinary tract urothelial carcinoma.
    Yeh BW; Wu WJ; Li WM; Li CC; Huang CN; Kang WY; Liu ZM; Huang HS
    Am J Pathol; 2012 Sep; 181(3):1044-55. PubMed ID: 22771156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockage of JNK pathway enhances arsenic trioxide-induced apoptosis in human keratinocytes.
    Huang HS; Liu ZM; Hong DY
    Toxicol Appl Pharmacol; 2010 Apr; 244(2):234-41. PubMed ID: 20074581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two modes of ERK activation by TNF in keratinocytes: different cellular outcomes and bi-directional modulation by vitamin D.
    Ziv E; Rotem C; Miodovnik M; Ravid A; Koren R
    J Cell Biochem; 2008 May; 104(2):606-19. PubMed ID: 18080320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EMT and CSC-like properties mediated by the IKKβ/IκBα/RelA signal pathway via the transcriptional regulator, Snail, are involved in the arsenite-induced neoplastic transformation of human keratinocytes.
    Jiang R; Li Y; Xu Y; Zhou Y; Pang Y; Shen L; Zhao Y; Zhang J; Zhou J; Wang X; Liu Q
    Arch Toxicol; 2013 Jun; 87(6):991-1000. PubMed ID: 23069812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation.
    Chen H; Liu J; Zhao CQ; Diwan BA; Merrick BA; Waalkes MP
    Toxicol Appl Pharmacol; 2001 Sep; 175(3):260-8. PubMed ID: 11559025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrin-releasing peptide activates Akt through the epidermal growth factor receptor pathway and abrogates the effect of gefitinib.
    Liu X; Carlisle DL; Swick MC; Gaither-Davis A; Grandis JR; Siegfried JM
    Exp Cell Res; 2007 Apr; 313(7):1361-72. PubMed ID: 17349623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.